ReliaBull

AMFI Registered Mutual Fund Distributor

Mutual Fund Research

MORE FROM MUTUAL FUNDS

Nippon India Pharma Fund(G)

As on Apr-25-2025 change fund
493.23  up-10.01 (-1.99%)

fund objective

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

riskometer

Investors understand that their principal will be at very high risk

5-Years History
financial year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)250.18290.14270.59428.87481.27
Net Assets(Rs Crores) (as on 31-Mar-2025) 4260.99 4931.89 4304.46 7125.28 8080.97
Scheme Returns(%)(Absolute)77.3614.83-6.8558.2410.94
B'mark Returns(%)(Absolute)NANANANANA
Category Rank32/7543/7565/7617/9030/102
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2024-20254.0117.220.80-8.69
2023-202417.1011.2311.589.06
2022-2023-10.128.200.15-4.25
2021-202222.060.731.97-7.50
2020-202131.5919.5012.24-1.15
Top 10 holdings
company (%)
Sun Pharmaceutical Industries...13.43 
Divi's Laboratories Ltd.9.28 
Lupin Ltd.7.27 
Cipla Ltd.5.71 
Apollo Hospitals Enterprise Ltd.5.31 
Dr. Reddy's Laboratories Ltd.5.19 
Glaxosmithkline Pharmaceutical...3.61 
Vijaya Diagnostic Centre Ltd.3.53 
Abbott India Ltd.3.46 
Medplus Health Services Ltd.3.41 

Category

Sector Funds

Launch Date

05-Jun-04

Scheme Benchmark

NA

AUM ( in Cr.)

8,080.97

portfolio price to book value

8.65

investing style?

Large Growth

fund manager?

Sailesh Raj Bhan

inception date (regular plan)

05-Jun-04

expense ratio (regular plan) %

1.82

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs80.62
Hospital & Healthcare Services17.82
Business Support1.01

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes and benchmark
scheme name investment style inception date AUM in Cr. 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20048,080.9715.4620.0322.0914.0220.50
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Large-Growth 13-Jul-20184,914.6420.9724.2424.87NA21.30
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19993,610.5120.9923.6824.4311.9816.29
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-20151,183.6516.6020.2521.63NA12.17
UTI Healthcare Fund-Reg(G)Large-Growth 01-Aug-20051,042.0420.0220.1721.6011.0918.13
DSP Healthcare Fund-Reg(G)Large-Growth 30-Nov-20183,018.7614.9319.9324.02NA22.81
ITI Pharma & Healthcare Fund-Reg(G)Large-Growth 08-Nov-2021213.7816.0618.93NANA14.03
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019814.9513.1018.3719.22NA20.66
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20182,667.4016.8318.2022.15NA20.87
LIC MF Healthcare Fund-Reg(G)Large-Growth 28-Feb-201982.6916.3016.2517.21NA18.22
HDFC Pharma and Healthcare Fund-Reg(G)Large-Growth 04-Oct-20231,634.0828.13NANANA35.37
WOC Pharma and Healthcare Fund-Reg(G)Large-Growth 06-Feb-2024303.6226.95NANANA22.39
Kotak Healthcare Fund-Reg(G)Large-Growth 11-Dec-2023411.5413.49NANANA19.86
Quant Healthcare Fund-Reg(G)Large-Growth 17-Jul-2023369.934.96NANANA23.40
PGIM India Healthcare Fund-Reg(G)Large-Growth 06-Dec-2024104.18NANANANA-5.00
Bajaj Finserv Healthcare Fund-Reg(G)Large-Growth 27-Dec-2024307.40NANANANA-8.19
Bandhan BSE Healthcare Index Fund-Reg(G)Large-Growth 06-Sep-202417.34NANANANA-4.11
Attention InvestorsKYC
Contact Us

Mobile No : +91 99674 32226
Email id : service@reliabullwealth.com

OUR OFFICE

ReliaBull Financial Services Private Limited,
No 4-D, 4th Floor, Victoria Plaza,
SV Road, Above Kora Showroom,
Santacruz West,
Mumbai – 400054

Informations : 
Useful Links : 
Subscribe

For all the Latest Market News, Investment Ideas.

GET OTP
subscribe
Follow us

AMFI Registration No:88227

ARN Initial Registration Date: 05-Mar-2013

ARN Expiry Date: 04-Mar-2025

A Reliabull Financial Services Venture

Designed & Developed by ●●● Accord Fintech Pvt. Ltd.